Owner General Incorporated Association Pharma Valley Project Supporting Organization Kumamoto Health Science University Kabushiki Kaisha Yakult Honsha Pharma Design, Inc. Shizuoka Prefecture

Inventors Asai, Akira; Matsuno, Kenji; Ogo, Naohisa; Takahashi, Osamu; Masuda, Yoshiaki; Muroya, Ayumu; Akiyama, Yasuto; Ashizawa, Tadashi; Okawara, Tadashi

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2010339271

PCT Pub. Number WO2011/081205

Priority 2009-297960 28.12.09 JP

Filing date 28 December 2010

Wipo publication date 7 July 2011

C07D 413/04 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/4245 - Oxadiazoles

A61K 31/428 - condensed with carbocyclic rings

A61K 31/437

A61K 31/4439

A61K 31/4545

A61K 31/55 - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 35/00 Antineoplastic agents

A61P 43/00 Drugs for specific purposes, not provided for in groups

C07D 413/14 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/14 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 487/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

C07D 498/04 Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 513/04 Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or